Neuron Guard is developing a medical device the new standard of care for targeted temperature management of brain damages.
Neuron Guard has raised $751K in total funding. The most recent round was Debt Financing. The last funding was announced in November 2021.
Neuron Guard's investors include CDP Venture Capital, A11 Venture, Fondo Rilancio Startup.
Neuron Guard is headquartered in Modena, Italy.
Neuron Guard is developing a medical device the new standard of care for targeted temperature management of brain damages.
Neuron Guard is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuron Guard — Funding & Investors." VCBacked, November 5, 2021, https://www.vcbacked.co/company/neuron-guard. Accessed September 30, 2026.
VCBacked. (2021). Neuron Guard — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/neuron-guard
{{cite web |title=Neuron Guard — Funding & Investors |url=https://www.vcbacked.co/company/neuron-guard |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated